First AD

Second AD

COVID-19

COVID-19 page, resources on the topics of medical news and expert insight into coronavirus can be found. Content includes articles, interviews, videos, podcasts, and breaking news on COVID-19 research, treatment, and drug development.

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Recent Approvals in Vaccination Against SARS-CoV-2 and the Omicron Subvariants

Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.

Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations

Overview of SARS-CoV-2 Virus and Subvariants

Defining Variants of Interest vs Variants of Concern

Impact of SARS-CoV-2 Subvariants on Vaccination

COVID-19 Booster Vaccination Protection Rates

Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination

CDC and FDA Recommendations for SARS-CoV-2 Booster Shots

Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots

Long-Term Data on SARS-CoV-2 Booster Shots

Initiating Patient Conversations Around SARS-CoV-2 Booster Shots

Safety of SARS-CoV-2 Bivalent Booster Shots

Impact of COVID-19 Pandemic on Antimicrobial Resistance

Addressing Vaccine Hesitancy and Uptake for SARS-CoV-2